ENVB
Closed
Enveric Biosciences Inc
1.23
+0.02 (+1.65%)
Last Update: 01 Jul 2025 23:11:00
Yesterday: 1.21
Day's Range: 1.2 - 1.2498
Send
sign up or login to leave a comment!
When Written:
1.6642
Enveric Biosciences Inc is a clinical-stage biotechnology company that focuses on developing novel therapies for patients suffering from cancer and other serious diseases. The company's lead product candidate is a cannabinoid-based therapy for the treatment of chemotherapy-induced neuropathic pain and other cancer-related symptoms. The company is also developing other cannabinoid-based therapies for the treatment of cancer, as well as non-cancer indications such as multiple sclerosis and epilepsy. Enveric Biosciences was founded in 2018 and is headquartered in New York City. Its stock is traded on the NASDAQ under the ticker symbol ENVB.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








